AgeX Therapeutics Inc AGE:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/23/22 EDT
0.57quote price arrow down-0.03 (-4.99%)
Volume
1,501
Close
0.6036quote price arrow down-0.0264 (-4.1905%)
Volume
9,425
52 week range
0.52 - 1.39
Loading...
  • Open0.5967
  • Day High0.65
  • Day Low0.5967
  • Prev Close0.63
  • 52 Week High1.39
  • 52 Week High Date12/31/21
  • 52 Week Low0.52
  • 52 Week Low Date12/20/21

Key Stats

  • Market Cap22.91M
  • Shares Out37.95M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.46
  • YTD % Change-44.62

KEY STATS

  • Open0.5967
  • Day High0.65
  • Day Low0.5967
  • Prev Close0.63
  • 52 Week High1.39
  • 52 Week High Date12/31/21
  • 52 Week Low0.52
  • 52 Week Low Date12/20/21
  • Market Cap22.91M
  • Shares Out37.95M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.46
  • YTD % Change-44.62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.25
  • P/E (TTM)-2.43
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-7.053M
  • ROE (TTM)-3,235.47%
  • Revenue (TTM)70,000.00
  • Gross Margin (TTM)85.29%
  • Net Margin (TTM)-13,880.88%
  • Debt To Equity (MRQ)-103.83%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AgeX Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
AgeX Therapeutics Inc. is a biotechnology company that is focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. The Company's product pipeline includes two cell-based therapies, which is derived from telomerase-positive pluripotent stem cells (PSCs) and two product candidates, which is derived from its induced Tissue Regeneration (iTRTM) technology. The Company's AGEX-BAT1 is being developed for the treatment of...
Joanne Hackett Ph.D.
Non-Executive Independent Chairman of the Board
Michael West Ph.D.
Chief Executive Officer, Founder, Director
Nafees Malik
Chief Operating Officer
Andrea Park
Chief Financial Officer
Address
1101 MARINA VILLAGE PARKWAY, SUITE 201
Alameda, CA
94501
United States